{"id":2564,"date":"2022-02-22T22:53:13","date_gmt":"2022-02-22T22:53:13","guid":{"rendered":"http:\/\/depts.washington.edu\/tlcart\/?p=2564"},"modified":"2023-06-02T10:40:41","modified_gmt":"2023-06-02T17:40:41","slug":"tlc-art-lab-update-on-hiv-therapies-at-leap-conference","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/tlcart\/tlc-art-lab-update-on-hiv-therapies-at-leap-conference\/","title":{"rendered":"TLC-ART Lab Update on HIV Therapies at LEAP Conference"},"content":{"rendered":"<p><img decoding=\"async\" class=\"wp-image-2568 alignnone\" src=\"https:\/\/depts.washington.edu\/tlcart\/wp-content\/uploads\/LEAP-Long-300x46.png\" alt=\"LEAP Logo\" width=\"25%\" height=\"25%\" srcset=\"https:\/\/depts.washington.edu\/tlcart\/wp-content\/uploads\/LEAP-Long-300x46.png 300w, https:\/\/depts.washington.edu\/tlcart\/wp-content\/uploads\/LEAP-Long-1024x158.png 1024w, https:\/\/depts.washington.edu\/tlcart\/wp-content\/uploads\/LEAP-Long-375x58.png 375w, https:\/\/depts.washington.edu\/tlcart\/wp-content\/uploads\/LEAP-Long-750x116.png 750w, https:\/\/depts.washington.edu\/tlcart\/wp-content\/uploads\/LEAP-Long-1140x176.png 1140w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n<p><strong>Seattle, WA<\/strong> (Feb 12, 2022)&#8211;Earlier this month, Dr. Rodney Ho presented updates on the TLC-ART program&#8217;s <a href=\"https:\/\/unitaid.org\/project\/long-acting-injections-to-treat-hiv\/#en\">Unitaid funded<\/a> Global Long-Acting Drug Development (GLAD) Project at the LEAP (Lon-Acting\/Extended Release Antiretroviral Research Resource Program) annual meeting.<\/p>\n<p>As part of this meeting, Dr. Ho lectured on the progress of the GLAD project in transforming the current best-of-class oral daily 3-drug pill (Tenofovir, Lamivudine, and Dolutegravir) into a long-acting injectable therapy that can improve patient adherence and provide a higher quality of life for People Living with HIV (PLHIV) globally.<\/p>\n<p>See the full lecture <a href=\"https:\/\/longactinghiv.org\/files\/inline-files\/RodneyHo-LEAP2022.mp4\">here<\/a>.<\/p>\n<p>For the complete set of presentations, see the agenda <a href=\"https:\/\/longactinghiv.org\/content\/LEAP-WORKSHOP-2022\">here<\/a>.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p><img decoding=\"async\" class=\" wp-image-2568 alignleft\" src=\"https:\/\/depts.washington.edu\/tlcart\/wp-content\/uploads\/LEAP-Long-300x46.png\" alt=\"LEAP Logo\" width=25% height=25% srcset=\"https:\/\/depts.washington.edu\/tlcart\/wp-content\/uploads\/LEAP-Long-300x46.png 300w, https:\/\/depts.washington.edu\/tlcart\/wp-content\/uploads\/LEAP-Long-1024x158.png 1024w, https:\/\/depts.washington.edu\/tlcart\/wp-content\/uploads\/LEAP-Long-375x58.png 375w, https:\/\/depts.washington.edu\/tlcart\/wp-content\/uploads\/LEAP-Long-750x116.png 750w, https:\/\/depts.washington.edu\/tlcart\/wp-content\/uploads\/LEAP-Long-1140x176.png 1140w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n<p><strong>Seattle, WA<\/strong> (Feb 12, 2022)&#8211;Earlier this month, Dr. Rodney Ho presented updates on the TLC-ART program&#8217;s <a href=\"https:\/\/unitaid.org\/project\/long-acting-injections-to-treat-hiv\/#en\">Unitaid funded<\/a> Global Long-Acting Drug Development (GLAD) Project at the LEAP (Lon-Acting\/Extended Release Antiretroviral Research Resource Program) annual meeting.<\/p>\n<p>As part of this meeting, Dr. Ho lectured on the progress of the GLAD project in transforming the current best-of-class oral daily 3-drug pill (Tenofovir, Lamivudine, and Dolutegravir) into a long-acting injectable therapy that can improve patient adherence and provide a higher quality of life for People Living with HIV (PLHIV) globally.<\/p>\n<div><a class=\"more-link\" href=\"https:\/\/depts.washington.edu\/tlcart\/tlc-art-lab-update-on-hiv-therapies-at-leap-conference\/\">Continue reading <span class=\"screen-reader-text\">TLC-ART Lab Update on HIV Therapies at LEAP Conference<\/span><\/a><\/div>\n","protected":false},"author":4,"featured_media":2567,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"gallery","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-2564","post","type-post","status-publish","format-gallery","has-post-thumbnail","hentry","category-news","post_format-post-format-gallery"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/posts\/2564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/comments?post=2564"}],"version-history":[{"count":15,"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/posts\/2564\/revisions"}],"predecessor-version":[{"id":2870,"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/posts\/2564\/revisions\/2870"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/media\/2567"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/media?parent=2564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/categories?post=2564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/tlcart\/wp-json\/wp\/v2\/tags?post=2564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}